- Home
- SERV vs VSTM Comparison
SERV vs VSTM Comparison
Compare SERV & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERV
- VSTM
- Stock Information
- Founded
- SERV 2017
- VSTM 2010
- Country
- SERV United States
- VSTM United States
- Employees
- SERV N/A
- VSTM N/A
- Industry
- SERV Industrial Specialties
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- SERV Consumer Discretionary
- VSTM Health Care
- Exchange
- SERV Nasdaq
- VSTM Nasdaq
- Market Cap
- SERV 609.5M
- VSTM 598.2M
- IPO Year
- SERV N/A
- VSTM 2012
- Fundamental
- Price
- SERV $12.76
- VSTM $9.48
- Analyst Decision
- SERV Buy
- VSTM Strong Buy
- Analyst Count
- SERV 5
- VSTM 9
- Target Price
- SERV $17.75
- VSTM $13.38
- AVG Volume (30 Days)
- SERV 8.0M
- VSTM 2.6M
- Earning Date
- SERV 11-06-2025
- VSTM 11-05-2025
- Dividend Yield
- SERV N/A
- VSTM N/A
- EPS Growth
- SERV N/A
- VSTM N/A
- EPS
- SERV N/A
- VSTM N/A
- Revenue
- SERV $1,479,483.00
- VSTM $2,137,000.00
- Revenue This Year
- SERV $133.00
- VSTM $88.50
- Revenue Next Year
- SERV $795.71
- VSTM $398.66
- P/E Ratio
- SERV N/A
- VSTM N/A
- Revenue Growth
- SERV N/A
- VSTM N/A
- 52 Week Low
- SERV $4.66
- VSTM $2.54
- 52 Week High
- SERV $24.35
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- SERV 64.62
- VSTM 57.51
- Support Level
- SERV $11.26
- VSTM $9.10
- Resistance Level
- SERV $13.12
- VSTM $10.06
- Average True Range (ATR)
- SERV 0.83
- VSTM 0.69
- MACD
- SERV 0.22
- VSTM -0.17
- Stochastic Oscillator
- SERV 82.86
- VSTM 25.76
About SERV Serve Robotics Inc. Common Stock
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.